# Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome

> **NCT07691645** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Xiang-Qian** · enrollment: 120 (estimated)

## Conditions studied

- HCC - Hepatocellular Carcinoma
- Chinese Herbal Medicine
- ICG (Indocyanine Green)
- Overall Survival (All-cause Mortality)
- Quality of Life

## Interventions

- **DRUG:** Shuganhuazhuo Formula
- **DRUG:** Targeted therapy
- **DRUG:** Immunotherapy
- **DRUG:** Chemotherapy
- **PROCEDURE:** TACE
- **PROCEDURE:** HAIC

## Key facts

- **NCT ID:** NCT07691645
- **Lead sponsor:** Xiang-Qian
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-09-01
- **Primary completion:** 2030-08-31
- **Final completion:** 2032-08-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691645, "Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*